International Journal of Sports Medicine – Ethical Standards in Sport and Exercise Science Research

D. Harriss,G. Atkinson

DOI: https://doi.org/10.1055/s-0029-1237378

2009-10-01

International Journal of Sports Medicine

Abstract:

What problem does this paper attempt to address?

Bacterial coinfections and secondary infections in COVID-19 patients from a tertiary care hospital of northern India: Time to adhere to culture-based practices

Bhawna Sharma,Priya Sreenivasan,Manisha Biswal,Varun Mahajan,Vikas Suri,Inderpaul Singh Sehgal,Pallab Ray,Goverdhan Dutt Puri,Ashish Bhalla,Lakshmi Narayana Yaddanapudi,Vipin Koushal,Archana Angrup

DOI: https://doi.org/10.5339/qmj.2021.62

2021-10-25

Abstract:Objective: Bacterial co-pathogens are common in various viral respiratory tract infections, leading to increased disease severity and mortality. Still, they are understudied during large outbreaks and pandemics. This study was conducted to highlight the overall burden of these infections in COVID-19 patients admitted to our tertiary care hospital, along with their antibiotic susceptibility patterns. Material and methods: During the six-month study period, clinical samples (blood samples, respiratory samples, and sterile body fluids, including cerebrospinal fluid [CSF]) of COVID-19 patients with suspected bacterial coinfections (at presentation) or secondary infections (after 48 hours of hospitalization) were received and processed for the same. Results: Clinical samples of 814 COVID-19 patients were received for bacterial culture and susceptibility. Out of the total patient sample, 75% had already received empirical antibiotics before the samples were sent for analysis. Overall, 17.9% of cultures were positive for bacterial infections. Out of the total patients with bacterial infection, 74% (108/146) of patients had secondary bacterial infections (after 48 hours of hospitalization) and 26% (38/146) had bacterial coinfections (at the time of admission). Out of the 143 total isolates obtained, the majority (86%) were gram-negative organisms, of which Acinetobacter species was the commonest organism (35.6%), followed by Klebsiella pneumoniae (18.1%). The majority (50.7%) of the pathogenic organisms reported were multidrug resistant. Conclusion: The overall rate of secondary bacterial infections (SBIs) in our study was lower (7.9%) than reported by other studies. A rational approach would be to adhere to the practice of initiating culture-based guidance for antibiotics and to restrict unnecessary empirical antimicrobial therapy.
Secondary bacterial infections in critical ill patients of COVID-19

Yiqi Fu,Qing Yang,Min Xu,Haishen Kong,Hongchao Chen,Yajie Fu,Yake Yao,Hua Zhou,Jianying Zhou

2020-01-01

Open Forum Infectious Diseases

Abstract:Secondary bacterial infections occurred in 13 9% (5/36) of critical ill patients of COVID-19 All the five patients had been admitted to ICU and received mechanical ventilation before episode of bacterial infection Active surveillance of culture should be performed for critical ill patients Prevention of nosocomial infection needs to be taken seriously
Profile of Co-Infection Prevalence and Antibiotics Use among COVID-19 Patients

Rita Greco,Vittorio Panetta,Maria Teresa Della Rocca,Adriana Durante,Giovanni Di Caprio,Paolo Maggi

DOI: https://doi.org/10.3390/pathogens11111250

IF: 3.7

2022-10-28

Pathogens

Abstract:Bacterial co-infection in COVID-19 patients significantly contributes to the worsening of the prognosis based on morbidity and mortality. Information on the co-infection profile in such patients could help to optimize treatment. The purpose of this study was to describe bacterial co-infections associated with microbiological, clinical, and laboratory data to reduce or avoid a secondary infection. A retrospective cohort study was conducted at Sant'Anna and San Sebastiano Hospital from January 2020 to December 2021. Bacterial co-infection was detected in 14.3% of the COVID-19-positive patients. The laboratory findings on admission showed significant alterations in the median D-dimer, C-reactive protein, interleukin-6, and lactate dehydrogenase values compared to normal values. All inflammatory markers were significantly elevated. The most common pathogens isolated from blood cultures were E. faecalis and S. aureus. Instead, the high prevalence of respiratory tract infections in the COVID-19 patients was caused by P. aeruginosa (41%). In our study, 220 (82.4%) of the COVID-19 patients received antimicrobial treatment. Aminoglycosides and β-lactams/β-lactamase inhibitors showed the highest resistance rates. Our results showed that older age, underlying conditions, and abnormal laboratory parameters can be risk factors for co-infection in COVID-19 patients. The antibiotic susceptibility profile of bacterial pathogen infection provides evidence on the importance, for the clinicians, to rationalize and individualize antibiotic usage.
Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis

Bradley J Langford,Miranda So,Sumit Raybardhan,Valerie Leung,Duncan Westwood,Derek R MacFadden,Jean-Paul R Soucy,Nick Daneman,Bradley J. Langford,Derek R. MacFadden,Jean-Paul R. Soucy

DOI: https://doi.org/10.1016/j.cmi.2020.07.016

IF: 13.31

2020-12-01

Clinical Microbiology and Infection

Abstract:BackgroundBacterial co-pathogens are commonly identified in viral respiratory infections and are an important cause of morbidity and mortality. The prevalence of bacterial infection in patients infected with SARS-CoV-2 is not well understood.ObjectiveTo determine the prevalence of bacterial co-infection (at presentation) and secondary infection (after presentation) in patients with COVID-19.Data SourcesWe performed a systematic search of MEDLINE, OVID Epub and EMBASE databases for English language literature from 2019 to April 16 2020.Study Eligibility CritieraStudies were included if they 1) evaluated patients with confirmed COVID-19 and 2) reported the prevalence of acute bacterial infection.MethodsData were extracted by a single reviewer and cross-checked by a second reviewer. The main outcome was the proportion of COVID-19 patients with an acute bacterial infection. Any bacteria detected from non-respiratory tract or non-bloodstream source were excluded.ResultsOf 1308 studies screened, 28 were eligible and included in the rapid review representing 3448 patients with COVID-19 evaluated for acute bacterial infection. In the meta-analysis, bacterial co-infection (estimated on presentation) was identified in 3.5% of patients (95%CI 0.6 to 6.5%) and secondary bacterial infection in 15.5% of patients (95%CI 10.9 to 20.1%). The overall proportion of COVID-19 patients with bacterial infection was 7.1% (95%CI 4.6 to 9.6%). Bacterial infection was more common in critically ill patients 8.1% (95%CI 2.3 to 13.8). The majority of patients with COVID-19 received antibiotics (71.3%, 95%CI 57.1 to 85.5%).ConclusionsBacterial co-infection is relatively infrequent in hospitalized patients with COVID-19. The majority of these patients may not require empiric antibacterial treatment.PROSPERO Registration CRD42020180229.

infectious diseases,microbiology
Bacterial and fungal secondary infections occurring in COVID-19 patients followed in intensive care: a retrospective study

Erhan Ozyurt,Aylin Erman Daloglu,Kerem Inanoglu,Nilgun Kavrut Ozturk,Sadik Ozmen

DOI: https://doi.org/10.3855/jidc.18480

2024-03-31

The Journal of Infection in Developing Countries

Abstract:Introduction: We aimed to investigate the effects of secondary bacterial and fungal infections on patient outcomes in patients followed up in the intensive care unit (ICU) due to coronavirus disease 2019 (COVID-19). Methodology: We retrospectively analyzed reverse transcriptase polymerase chain reaction (RT-PCR) positive COVID-19 patients followed in the ICU of our hospital between March 2020 and June 2021, using the hospital information system. Demographic data, pathogens causing a secondary infection, onset time of secondary infection, and patient outcomes were recorded. Results: A total of 251 RT-PCR positive patients who met the inclusion criteria were evaluated. The mean length of stay (LOS) in the ICU was 13.3 ± 9.6 days. During this period, 165 (65.7%) patients died. When blood, urine, respiratory tract, and catheter cultures were examined, the number of patients with growth in at least one culture was 129 (51.4%). There was growth in a total of 227 cultures. The highest culture positivity rate was observed in respiratory tract samples (n = 94, 41.4%). Gram-negative bacterial pathogens (n = 130, 58.4%) predominated. Candida spp. was more frequent in urine cultures. The median day of the occurrence of secondary infection was 10 (range: 6-15). Patients who developed secondary infection had a longer LOS and higher mortality rate than patients who did not (p < 0.001). Conclusions: Gram-negative secondary infections, predominantly in respiratory tract cultures, occurred in COVID-19 patients followed in the ICU. As a result, the LOS was prolonged and mortality rates increased.

infectious diseases
Clinical and etiological analysis of co-infections and secondary infections in COVID-19 patients: An observational study

Shuyan Chen,Qing Zhu,Yanyu Xiao,Chi Wu,Zhaofang Jiang,Lei Liu,Jiuxin Qu

DOI: https://doi.org/10.1111/crj.13369

Abstract:Background: Co-infections, secondary bacterial or fungal infections, are important risk factors for poor outcomes in viral infections. The prevalence of co-infection and secondary infection in patients infected with SARS-CoV-2 is not well understood. Aims: To investigate the role of co-infections and secondary infections in disease severity of hospitalized individuals with COVID-19. Materials and methods: A retrospective study was carried out between 11 January 2020 and 1 March 2020 among 408 laboratory confirmed COVID-19 patients in China. These patients were divided into three groups based on disease severity: mild or moderate, severe, or critically ill. Microbiological pathogens in blood, urine, and respiratory tract specimens were detected by the combination of culture, serology, polymerase chain reaction, and metagenomic next-generation sequencing (mNGS). Results: The median age of participants was 48 years (IQR 34-60 years). Fifty-two patients (12.7%) had at least one additional pathogen, 8.1% were co-infected, and 5.1% had a secondary infection. There were 13 Mycoplasma pneumoniae cases, 8 Haemophilus influenzae cases, 8 respiratory viruses, and 3 Streptococcus pneumoniae cases, primarily detected in mild and moderate COVID-19 patients. Hospital-acquired infection pathogens were more common in critically ill patients. Compared to those without additional pathogens, patients with co-infections and/or secondary infections were more likely to receive antibiotics (p < 0.001) and have elevated levels of d-dimer (p = 0.0012), interleukin-6 (p = 0.0027), and procalcitonin (p = 0.0002). The performance of conventional culture was comparable with that of mNGS in diagnosis of secondary infections. Conclusion: Co-infections and secondary infections existed in hospitalized COVID-19 patients and were relevant to the disease severity. Screening of common respiratory pathogens and hospital infection control should be strengthened.
Etiology and antimicrobial resistance of secondary bacterial infections in patients hospitalized with COVID-19 in Wuhan, China: a retrospective analysis

Jie Li,Junwei Wang,Yi Yang,Peishan Cai,Jingchao Cao,Xuefeng Cai,Yu Zhang

DOI: https://doi.org/10.1186/s13756-020-00819-1

IF: 6.454

2020-09-22

Antimicrobial Resistance and Infection Control

Abstract:Abstract Background A considerable proportion of patients hospitalized with coronavirus disease 2019 (COVID-19) acquired secondary bacterial infections (SBIs). The etiology and antimicrobial resistance of bacteria were reported and used to provide a theoretical basis for appropriate infection therapy. Methods This retrospective study reviewed electronic medical records of all the patients hospitalized with COVID-19 in the Wuhan Union Hospital between January 27 and March 17, 2020. According to the inclusion and exclusion criteria, patients who acquired SBIs were enrolled. Demographic, clinical course, etiology, and antimicrobial resistance data of the SBIs were collected. Outcomes were also compared between patients who were classified as severe and critical on admission. Results Among 1495 patients hospitalized with COVID-19, 102 (6.8%) patients had acquired SBIs, and almost half of them (49.0%, 50/102) died during hospitalization. Compared with severe patients, critical patients had a higher chance of SBIs. Among the 159 strains of bacteria isolated from the SBIs, 136 strains (85.5%) were Gram-negative bacteria. The top three bacteria of SBIs were A. baumannii (35.8%, 57/159), K. pneumoniae (30.8%, 49/159), and S. maltophilia (6.3%, 10/159). The isolation rates of carbapenem-resistant A. baumannii and K. pneumoniae were 91.2 and 75.5%, respectively. Meticillin resistance was present in 100% of Staphylococcus aureus and Coagulase negative staphylococci , and vancomycin resistance was not found. Conclusions SBIs may occur in patients hospitalized with COVID-19 and lead to high mortality. The incidence of SBIs was associated with the severity of illness on admission. Gram-negative bacteria, especially A. baumannii and K. pneumoniae, were the main bacteria, and the resistance rates of the major isolated bacteria were generally high. This was a single-center study; thus, our results should be externally examined when applied in other institutions.

infectious diseases,public, environmental & occupational health,microbiology
Pattern of Bacterial and Fungal Infections among Hospitalized Patients with COVID-19 versus non COVID-19 Community Acquired Pneumonia

Basma Mohammed,Ahmed Sadek,Islam G. Sayed,Mohamed M. Amin,Islam Sayed,Mohamed Amin

DOI: https://doi.org/10.21608/ejmm.2023.319216

2023-10-01

Egyptian Journal of Medical Microbiology

Abstract:Background: It is strongly believed that co-infections play an important role during COVID-19 outbreak. Furthermore, secondary bacterial pneumonia rates increase rapidly in intensive care unit patients. Objectives: This study aimed to elucidate the rate of bacterial and fungal contagions among the hospitalized COVID-19 patients and compares it with non-COVID-19 community acquired pneumonia (CAP) cases with documentation of the most common organisms to guarantee the responsible use of antibiotics among these cases. Methodology: 100 patients were admitted with confirmed CAP and classified into 2 groups according to SARS-CoV-2 PCR results; the first group consisted of 52 COVID-19 positive patients. The second group included 48 patients with non- COVID-19 CAP. Results: COVID-19 group showed several negative sputum cultures than the non-COVID-19 group (p=0.023). Within the cases with positive cultures, COVID-19 patients had more (Staph. aureus, E. coli, Klebsiella pneumoniae and Candida albicans). While non-COVID-19 patients had more (Streptococcus, Pseudomonas aeruginosa, Enterococcus and Proteus) (p <0.05). COVID-19 cases had further resistant strains (p =0.031). Regarding the outcome findings, there were considerable increase in duration of the hospital stay (LHS), necessity of oxygen support and mechanical ventilation among COVID-19 group [p <0.05] with a higher decease rate among COVID-19 group. Conclusions: Critically ill COVID-19 patients exhibited a higher rate of bacterial co-infection detected in sputum (80.8%), PSI, LHS, necessity for oxygen, mechanical ventilation and mortality were higher in COVID-19 CAP compared with non-COVID-19 CAP PSI, LHS, necessity for oxygen, mechanical ventilation and decease rate which were higher among COVID-19 cases compared with non-COVID-19 CAP.
Secondary infection in COVID-19 critically ill patients: a retrospective single-center evaluation

Astrid De Bruyn,Stijn Verellen,Liesbeth Bruckers,Laurien Geebelen,Ina Callebaut,Ilse De Pauw,Björn Stessel,Jasperina Dubois

DOI: https://doi.org/10.1186/s12879-022-07192-x

2022-03-02

Abstract:Background: Patients infected with severe acute respiratory syndrome coronavirus (SARS-CoV-2) can develop severe illness necessitating intensive care admission. Critically ill patients are susceptible for the development of secondary bacterial infections. Due to a combination of virus- and drug-induced immunosuppression, critically ill patients with corona virus disease 2019 (COVID-19) may even have a higher risk of developing a secondary infection. These secondary infections can aggravate the severity of illness and increase the risk of death. Further research on secondary infections in COVID-19 patients is essential. Therefore, the objective of this study was to investigate the incidence and associated risk factors of secondary bacterial infections and to identify the most common groups of pathogens in critically ill COVID-19 patients. Methods: This mono-center, retrospective observational cohort study was performed at the intensive care unit (ICU) of the Jessa Hospital, Hasselt, Belgium. All adult COVID-19 patients admitted to the ICU from 13th March 2020 until 17th October 2020, were eligible for inclusion in the study. Data from the resulting 116 patients were prospectively entered into a customized database. The resulting database was retrospectively reviewed to investigate three types of secondary bacterial infections (secondary pneumonia, bloodstream infections of unknown origin, catheter-related sepsis). Results: Of 94 included patients, 68% acquired at least one of the studied secondary bacterial infections during their ICU stay. Almost two thirds of patients (65.96%, n = 62) acquired a secondary pneumonia, whereas 29.79% (n = 28) acquired a bacteremia of unknown origin and a smaller proportion of patients (14.89%, n = 14) acquired a catheter-related sepsis. Male gender (P = 0.05), diabetes mellitus (P = 0.03) and the cumulative dose of corticosteroids (P = 0.004) were associated with increased risk of secondary bacterial infection. The most common pathogens detected in the cultures of patients with secondary pneumonia were Gram-negative bacilli. Bacteremia of unknown origin and catheter-related sepsis were mostly caused by Gram-positive cocci. Conclusion: This study confirms that the incidence of secondary bacterial infections is very high in critically ill COVID-19 patients. These patients are at highest risk of developing secondary pneumonia. Male gender, a history of diabetes mellitus and the administration of corticosteroids were associated with increased risk of secondary bacterial infection.
Secondary Bacterial Infection and Clinical Characteristics in Patients With COVID-19 Admitted to Two Intensive Care Units of an Academic Hospital in Iran During the First Wave of the Pandemic

Samaneh Pourajam,Elham Kalantari,Hamid Talebzadeh,Hamid Mellali,Ramin Sami,Forogh Soltaninejad,Babak Amra,Mahdi Sajadi,Malihe Alenaseri,Forough Kalantari,Hamid Solgi

DOI: https://doi.org/10.3389/fcimb.2022.784130

IF: 6.073

2022-02-23

Frontiers in Cellular and Infection Microbiology

Abstract:Data on the prevalence of bacterial co-infections and secondary infection among adults with COVID-19 admitted to the intensive care unit (ICU) are rare. We aimed to determine the frequency of secondary bacterial infection, antibiotic use, and clinical characteristics in patients admitted to the ICU with severe SARS-CoV-2 pneumonia. This was a retrospective cohort study of adults with severe COVID-19 admitted to two ICUs from March 6 to September 7, 2020 in an academic medical center in Isfahan, Iran. To detect COVID-19, reverse transcription real-time polymerase chain reaction was performed and also typical pattern of CT scan was used for the diagnosis of COVID-19. Data collection included the age, gender, main symptoms, history of underlying disease, demographics, hospital stay, outcomes, and antibiotic regimen of the patient. Antimicrobial susceptibility testing was carried out according to the CLSI guidelines. During the study period, 553 patients were referred to the both ICUs for COVID-19 with severe pneumonia. Secondary bacterial infection was detected in 65 (11.9%) patients. The median age was 69.4 (range 21–95) years; 42 (63.6%) were men. Notably, 100% (n = 65) of the patients with superinfection were prescribed empirical antibiotics before first positive culture, predominantly meropenem (86.2%) with a median duration of 12 (range 2–32) days and levofloxacin (73.8%) with a median duration of nine (range 2–24) days. Most prevalent causative agents for secondary bacterial infection were Klebsiella pneumoniae (n = 44) and Acinetobacter baumannii (n = 33). Most patients with secondary bacterial infection showed extensive drug-resistance. The mortality among patients who acquired superinfections was 83% against an overall mortality of 38.1% in total admitted COVID-19 patients. We found a high prevalence of carbapenem-resistant Gram-negative bacilli in COVID-19 patients admitted to our ICUs, with a high proportion of K. pneumoniae followed by A. baumannii . These findings emphasize the importance of implementation of strict infection control measures and highlight the role of antimicrobial stewardship during a pandemic.

immunology,microbiology
Emerging Concern from Short-Term Textile Leaching: A Preliminary Ecotoxicological Survey

G. Lofrano,G. Libralato,M. Carotenuto,M. Guida,M. Inglese,A. Siciliano,S. Meriç

DOI: https://doi.org/10.1007/s00128-016-1937-x

2016-10-04

Bulletin of Environmental Contamination and Toxicology

Abstract:
Bloodstream Coinfections and Antimicrobial Resistance in Hospitalized COVID-19 Patients: A Single-center Retrospective Study

Yu-Hsin Tsai,Tai-Cheng Hou,Po-Yu Liu,Chih-Jung Chen,Jiunn-Min Wang

DOI: https://doi.org/10.21873/invivo.13653

In Vivo

Abstract:Background/aim: Bloodstream infections in patients with COVID-19 are linked to higher mortality rates, whilst data on epidemiology and resistance patterns remains scarce to guide management and prevent antibiotic resistance. This research focuses on the prevalence, clinical features, causative microorganisms, and antimicrobial susceptibility of bacterial and fungal secondary bloodstream co-infections in hospitalized patients with COVID-19. Patients and methods: In this retrospective study analysis of 230 patients with COVID-19 from Central Taiwan (June 2021 to June 2022), pathogens were identified via MALDI-TOF MS and Vitek 2 system with Clinical & Laboratory Standards Institute (CLSI) standards. Results: In the cohort, 17.8% experienced bloodstream infections, resulting in a total of 45 isolates from the 41 bloodstream infection patients: predominantly gram-positive bacteria (Staphylococcus and Enterococcus) at 69%, gram-negative at 29% (Escherichia coli and Klebsiella pneumoniae), and fungi at 2%. Infected patients showed significantly elevated levels of white blood count (WBC), C-reactive protein (CRP) and procalcitonin (PCT). Of note, resistance to common antibiotics, such as fluoroquinolones, cephalosporins, and oxacillin was significant, especially in K. pneumoniae, Acinetobacter species, and S. aureus infections. Conclusion: Our study highlights the influence of bacterial infections in hospitalized patients with COVID-19. The bacterial infections were discovered to impact the clinical trajectory of COVID-19, potentially exacerbating or mitigating its symptoms, severity and fatality. These insights are pivotal to addressing clinical challenges in COVID-19 management and underscoring the need for tailored medical interventions. Understanding these co-infections is thus essential for optimizing patient care and improving overall outcomes in the post COVID-19 pandemic era.
Clinical characteristics and risk factors for bacterial co-infections in COVID-19 patients: A retrospective study

Yichuan Gan,Guowen Zhang,Hengbiao Sun,Xiaoming Lyu

DOI: https://doi.org/10.1016/j.jgar.2024.04.007

Abstract:Objective: This study aimed to analyse the bacterial composition, distribution, drug sensitivity, and clinical characteristics of patients with coronavirus disease 2019 (COVID-19) who develop bacterial co-infections. Methods: We conducted a retrospective study of 184 patients with COVID-19 admitted between December 2022 and January 2023. Data on gender, age, length of hospital stay, pneumonia classification, underlying diseases, invasive surgery, hormone therapy, inflammation indicators, and other relevant information were collected. Samples of sputum, bronchoscopy sputum, alveolar lavage fluid, middle urine, puncture fluid, wound secretions, and blood were collected for pathogen isolation, identification, and drug sensitivity testing. Results: The majority of patients with COVID-19 with bacterial co-infection were elderly and had underlying diseases. Invasive surgery and hormone therapy were identified as risk factors for co-infections. Laboratory analysis showed reduced lymphocyte counts and elevated levels of C-reactive protein and procalcitonin. The most common pathogens in co-infections were Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa. The detection rate of drug-resistant strains, including methicillin-resistant S. aureus, carbapenem-resistant K. pneumoniae, carbapenem-resistant A. baumannii, carbapenem-resistant P. aeruginosa, and carbapenem-resistant E. coli, increased with the severity of pneumonia. Conclusion: Respiratory tract infections were the most common site of bacterial co-infection in patients with COVID-19. Severe cases were more susceptible to multidrug-resistant pathogens, leading to a higher mortality rate. Timely control and prevention of co-infection are crucial for improving the prognosis of patients with COVID-19.
Secondary Infection in Severe and Critical COVID-19 Patients in China: a Multicenter Retrospective Study.

Ling Sang,Yin Xi,Zhimin Lin,Ying Pan,Bin Song,Chang-an Li,Xia Zheng,Ming Zhong,Li Jiang,Chun Pan,Wei Zhang,Zheng Lv,Jiaan Xia,Nanshan Chen,Wenjuan Wu,Yonghao Xu,Sibei Chen,Dongdong Liu,Weibo Liang,Xuesong Liu,Xiaoqing Liu,Shiyue Li,Nanshan Zhong,Dan Ye,Yuanda Xu,Nuofu Zhang,Dingyu Zhang,Yimin Li

DOI: https://doi.org/10.21037/apm-21-833

2021-01-01

Annals of Palliative Medicine

Abstract:BACKGROUND:Since 2020 COVID-19 pandemic became an emergent public sanitary incident. The epidemiology data and the impact on prognosis of secondary infection in severe and critical COVID-19 patients in China remained largely unclear.METHODS:We retrospectively reviewed medical records of all adult patients with laboratory-confirmed COVID-19 who were admitted to ICUs from January 18th 2020 to April 26th 2020 at two hospitals in Wuhan, China and one hospital in Guangzhou, China. We measured the frequency of bacteria and fungi cultured from respiratory tract, blood and other body fluid specimens. The risk factors for and impact of secondary infection on clinical outcomes were also assessed.RESULTS:Secondary infections were very common (86.6%) when patients were admitted to ICU for >72 hours. The majority of infections were respiratory, with the most common organisms being Klebsiella pneumoniae (24.5%), Acinetobacter baumannii (21.8%), Stenotrophomonas maltophilia (9.9%), Candida albicans (6.8%), and Pseudomonas spp. (4.8%). Furthermore, the proportions of multidrug resistant (MDR) bacteria and carbapenem resistant Enterobacteriaceae (CRE) were high. We also found that age ≥60 years and mechanical ventilation ≥13 days independently increased the likelihood of secondary infection. Finally, patients with positive cultures had reduced ventilator free days in 28 days and patients with CRE and/or MDR bacteria positivity showed lower 28-day survival rate.CONCLUSIONS:In a retrospective cohort of severe and critical COVID-19 patients admitted to ICUs in China, the prevalence of secondary infection was high, especially with CRE and MDR bacteria, resulting in poor clinical outcomes.
[The calcium dietary level modulates the development of genetic hypertension in rats].

R. Schleiffer,F. Pernot,A. Berthelot,A. Gairard

Abstract:In young male rat (Okamoto strain) hypertension develops more rapidly with a low calcium diet (0,03 per cent) and more slowly with a high calcium diet (1,2 per cent). Moreover hypertensive levels are slightly but statistically lessened after 9 months of high calcium diet. It appears that dietary calcium modulates development of genetic hypertension in the Rat.
Risks and Features of Secondary Infections in Severe and Critical Ill COVID-19 Patients

Haocheng Zhang,Yi Zhang,Jing Wu,Yang Li,Xian Zhou,Xin Li,Haili Chen,Mingquan Guo,Shu Chen,Feng Sun,Richeng Mao,Chao Qiu,Zhaoqin Zhu,Jingwen Ai,Wenhong Zhang

DOI: https://doi.org/10.1080/22221751.2020.1812437

2020-01-01

Emerging Microbes & Infections

Abstract:ObjectivesSevere or critical COVID-19 is associated with intensive care unit admission, increased secondary infection rate, and would lead to significant worsened prognosis. Risks and characteristics relating to secondary infections in severe COVID-19 have not been described.MethodsSevere and critical COVID-19 patients from Shanghai were included. We collected lower respiratory, urine, catheters, and blood samples according to clinical necessity and culture and mNGS were performed. Clinical and laboratory data were archived.ResultsWe found 57.89% (22/38) patients developed secondary infections. The patient receiving invasive mechanical ventilation or in critical state has a higher chance of secondary infections (P<0.0001). The most common infections were respiratory, blood-stream and urinary infections, and in respiratory infections, the most detected pathogens were gram-negative bacteria (26, 50.00%), following by gram-positive bacteria (14, 26.92%), virus (6, 11.54%), fungi (4, 7.69%), and others (2, 3.85%). Respiratory Infection rate post high flow, tracheal intubation, and tracheotomy were 12.90% (4/31), 30.43% (7/23), and 92.31% (12/13) respectively. Secondary infections would lead to lower discharge rate and higher mortality rate.ConclusionOur study originally illustrated secondary infection proportion in severe and critical COVID-19 patients. Culture accompanied with metagenomics sequencing increased pathogen diagnostic rate. Secondary infections risks increased after receiving invasive respiratory ventilations and intravascular devices, and would lead to a lower discharge rate and a higher mortality rate.
Secondary Bacterial Infections in Patients With Viral Pneumonia

Prasanth Manohar,Belinda Loh,Ramesh Nachimuthu,Xiaoting Hua,Susan C. Welburn,Sebastian Leptihn

DOI: https://doi.org/10.3389/fmed.2020.00420

IF: 3.9

2020-08-05

Frontiers in Medicine

Abstract:Pulmonary diseases of viral origin are often followed by the manifestation of secondary infections, leading to further clinical complications and negative disease outcomes. Thus, research on secondary infections is essential. Here, we review clinical data of secondary bacterial infections developed after the onset of pulmonary viral infections. We review the most recent clinical data and current knowledge of secondary bacterial infections and their treatment in SARS-CoV-2 positive patients; case reports from SARS-CoV, MERS-CoV, SARS-CoV2 and the best-studied respiratory virus, influenza, are described. We outline treatments used or prophylactic measures employed for secondary bacterial infections. This evaluation includes recent clinical reports of pulmonary viral infections, including those by COVID-19, that reference secondary infections. Where data was provided for COVID-19 patients, a mortality rate of 15.2% due to secondary bacterial infections was observed for patients with pneumonia (41 of 268). Most clinicians treated patients with SARS-CoV-2 infections with prophylactic antibiotics (63.7%, n = 1,901), compared to 73.5% (n = 3,072) in all clinical reports of viral pneumonia included in this review. For all cases of viral pneumonia, a mortality rate of 10.9% due to secondary infections was observed (53 of 482). Most commonly, quinolones, cephalosporins and macrolides were administered, but also the glycopeptide vancomycin. Several bacterial pathogens appear to be prevalent as causative agents of secondary infections, including antibiotic-resistant strains of Staphylococcus aureus and Klebsiella pneumoniae.

medicine, general & internal
Secondary Bacterial Infections in Critically Ill COVID-19 Patients Admitted in the Intensive Care Unit of a Tertiary Hospital in Romania

Ionela-Anca Pintea-Simon,Ligia Bancu,Anca Delia Mare,Cristina Nicoleta Ciurea,Felicia Toma,Mădălina Cristina Brukner,Anca-Meda Văsieșiu,Adrian Man

DOI: https://doi.org/10.3390/jcm13206201

IF: 3.9

2024-10-19

Journal of Clinical Medicine

Abstract:Background: The outbreak of the COVID-19 pandemic caught healthcare systems in many countries unprepared. Shortages of personnel, medicines, disinfectants, and intensive care unit (ICU) capacities, combined with inadvertent use of antibiotics and emergence of drug-resistant secondary infections, led to a surge in COVID-19-related mortality. Objective: We aimed to evaluate the prevalence of secondary bacterial infections and the associated antibiotic resistance in a temporary established ICU dedicated to COVID-19 patients. We also assessed the utility of clinical and routine laboratory data as predictors of secondary infections and mortality in these patients. Methods: We examined the medical records of 243 patients admitted to the COVID-19 Medical Support Unit of Târgu Mures, Romania, between 1 August 2020 and 31 January 2021. Results: Among the 243 patients admitted to the COVID-19 Medical Support Unit of Târgu Mures between 1 August 2020 and 31 January 2021, 59 (24.3%) presented secondary infections. Acinetobacter baumannii and Klebsiella pneumoniae were the most frequent isolates (31.1% and 18.9%, respectively), most of them multidrug resistant. Chronic obstructive pulmonary disease had a higher prevalence in patients who developed secondary infections (p = 0.012). Secondary infections were associated with longer stay in the ICU and with higher mortality (p = 0.006 and p = 0.038, respectively). Conclusions: Early identification of secondary infections and proper use of antibiotics are necessary to limit the spread of multidrug-resistant microorganisms in COVID-19 patients admitted in the ICU.

medicine, general & internal
Parents Seeking Health-Related Information on the Internet: Cross-Sectional Study

A. Bianco,R. Zucco,C. Nobile,C. Pileggi,M. Pavia

DOI: https://doi.org/10.2196/jmir.2752

IF: 7.076

2013-09-01

Journal of Medical Internet Research

Abstract:Background The Internet represents an increasingly common source of health-related information, and it has facilitated a wide range of interactions between people and the health care delivery system. Objective To establish the extent of Internet access and use to gather information about health topics and the potential implications to health care among the adult population in Calabria region, Italy. Methods This cross-sectional study was conducted from April to June 2012. The sample consisted of 1544 adults aged ≥18 years selected among parents of public school students in the geographic area of Catanzaro in southern Italy. A 2-stage sample design was planned. A letter summarizing the purpose of the study, an informed consent form, and a questionnaire were given to selected student to deliver to their parents. The final survey was formulated in 5 sections: (1) sociodemographic characteristics, (2) information about chronic diseases and main sources of health care information, (3) information about Internet use, (4) data about the effects of using the Internet to search for health information, and (5) knowledge and use of social networks. Results A total of 1039 parents completed the questionnaire, with a response rate equivalent to 67.29%. Regarding health-related information types, 84.7% of respondents used the Internet to search for their own medical conditions or those of family members or relatives, 40.7% of parents reported looking for diet, body weight, or physical activity information, 29.6% searched for vaccines, 28.5% for screening programs, and 16.5% for smoking cessation tools and products. The results of the multiple logistic regression analysis showed that parents who looked for health-related information on the Internet were more likely to be female (OR 1.53, 95% CI 1.05-2.25), with a high school diploma (OR 1.69, 95% CI 1.02-2.81) or college degree (OR 2.14, 95% CI 1.21-3.78), younger aged (OR 0.96, 95% CI 0.94-0.99), with chronic conditions (OR 1.94, 95% CI 1.17-3.19), not satisfied with their general practitioner’s health-related information (OR 0.6, 95% CI 0.38-0.97), but satisfied with information from scientific journals (OR 1.99, 95% CI 1.33-2.98). Conclusions Our analyses provide important insights into Internet use and health information–seeking behaviors of the Italian population and contribute to the evidence base for health communication planning. Health and public health professionals should educate the public about acquiring health information online and how to critically appraise it, and provide tools to navigate to the highest-quality information. The challenge to public health practice is to facilitate the health-promoting use of the Web among consumers in conjunction with their health care providers.
Prevalence, risk factors and outcomes of secondary infections among hospitalised patients with COVID-19 or post-COVID-19 conditions in Victoria, 2020-2023

Hugh C Murray,Michael Muleme,Darcie Cooper,Bridgette J McNamara,Mohammad A Hussain,Caroline Bartolo,Daniel P O'Brien,Eugene Athan

DOI: https://doi.org/10.1016/j.ijid.2024.107078

IF: 12.073

2024-05-02

International Journal of Infectious Diseases

Abstract:Objectives: Estimates of secondary infections are variedly reported, with few studies done in Australia. We investigated the occurrence and impact of secondary infections complicating COVID-19 and post-COVID-19 admissions in Victoria, Australia, 2020-2023. Methods : We used linked population-wide datasets and ICD-10 codes to identify and estimate occurrence of secondary infections. Using hospital/ICU length of stay (LOS) in negative binomial regression, and mortality, we examined the impact of secondary infections. Results: Secondary infections were identified in 6·9% (13,467/194,660) of COVID-19 and post-COVID-19 admissions; 6·0% (11,651/194,660) bacterial, 0·9% (1,691/194,660) viral, and 0·2% (385/194,660) fungal. Prevalence was highest during Pre-Delta (10.4%) and Omicron-BA2 (8.1%) periods. Sepsis and pneumonia were the most reported syndromes; occurrence of sepsis declined gradually over time. The odds of secondary infections were higher among the ≥70-year-olds (adjusted odds ratio(aOR):3·76 (95%CI: 3·43-4·14; vs 20-29-year-olds), individuals with chronic conditions (aOR:3·15; 95%CI: 2·88-3·45; vs those without), the unvaccinated (aOR:1·59; 95%CI: 1·45-1·75) and the lowest socio-economic group (aOR:1·12; 95%CI: 1·05-1·19). Patients with secondary infections had 2·43 times longer hospital LOS, and 9·60 times longer ICU LOS compared to those without. Mortality risk was 2·17 times higher in those with secondary infections. Conclusion: Secondary infections occurred in 69 per 1000 COVID-19 associated hospital admissions in Victoria, mostly in high-risk groups, and were associated with severe outcomes.

infectious diseases

International Journal of Sports Medicine – Ethical Standards in Sport and Exercise Science Research

Bacterial coinfections and secondary infections in COVID-19 patients from a tertiary care hospital of northern India: Time to adhere to culture-based practices

Secondary bacterial infections in critical ill patients of COVID-19

Profile of Co-Infection Prevalence and Antibiotics Use among COVID-19 Patients

Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis

Bacterial and fungal secondary infections occurring in COVID-19 patients followed in intensive care: a retrospective study

Clinical and etiological analysis of co-infections and secondary infections in COVID-19 patients: An observational study

Etiology and antimicrobial resistance of secondary bacterial infections in patients hospitalized with COVID-19 in Wuhan, China: a retrospective analysis

Pattern of Bacterial and Fungal Infections among Hospitalized Patients with COVID-19 versus non COVID-19 Community Acquired Pneumonia

Secondary infection in COVID-19 critically ill patients: a retrospective single-center evaluation

Secondary Bacterial Infection and Clinical Characteristics in Patients With COVID-19 Admitted to Two Intensive Care Units of an Academic Hospital in Iran During the First Wave of the Pandemic

Emerging Concern from Short-Term Textile Leaching: A Preliminary Ecotoxicological Survey

Bloodstream Coinfections and Antimicrobial Resistance in Hospitalized COVID-19 Patients: A Single-center Retrospective Study

Clinical characteristics and risk factors for bacterial co-infections in COVID-19 patients: A retrospective study

Secondary Infection in Severe and Critical COVID-19 Patients in China: a Multicenter Retrospective Study.

[The calcium dietary level modulates the development of genetic hypertension in rats].

Risks and Features of Secondary Infections in Severe and Critical Ill COVID-19 Patients

Secondary Bacterial Infections in Patients With Viral Pneumonia

Secondary Bacterial Infections in Critically Ill COVID-19 Patients Admitted in the Intensive Care Unit of a Tertiary Hospital in Romania

Parents Seeking Health-Related Information on the Internet: Cross-Sectional Study

Prevalence, risk factors and outcomes of secondary infections among hospitalised patients with COVID-19 or post-COVID-19 conditions in Victoria, 2020-2023